SCOPUS 정보 검색 플랫폼

Movement Disorders

Volumn 22, Issue 2, 2007, Pages 291-292

Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred [9]

(6) Gosal, David a Lynch, Timothy a Ross, Owen A b Haugarvoll, Kristoffer b Farrer, Matthew J b Gibson, J Mark c

a MATER MISERICORDIAE UNIVERSITY HOSPITAL (Ireland)

b MAYO CLINIC (United States)

c ROYAL VICTORIA HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYSTEINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLYCINE; LEUCINE RICH REPEAT KINASE 2;

ADULT; AMINO ACID SUBSTITUTION; CASE REPORT; DISEASE COURSE; DNA SEQUENCE; EXON; FAMILY HISTORY; HAPLOTYPE; HUMAN; LETTER; MALE; PARKINSON DISEASE; PENETRANCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; THALAMOTOMY; TREATMENT OUTCOME;

ARGININE; BINDING SITES; DISEASE PROGRESSION; GLYCINE; HISTIDINE; HUMANS; IRELAND; MALE; MIDDLE AGED; PARKINSON DISEASE; PENETRANCE; POINT MUTATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 33847718695 PISSN: 08853185 EISSN: 15318257 Source Type: Journal
DOI: 10.1002/mds.21200 Document Type: Letter

Times cited : (13)

References (7)

1
- 8844233579
- Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
- Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.
- (2004) Neuron , vol.44 , pp. 601-607
- Zimprich, A.¹ Biskup, S.² Leitner, P.³

2
- 33646151866
- LRRK2 in Parkinson's disease: Protein domains and functional insights
- Mata IF, Wedemeyer WJ, Farrer MJ, Taylor JP, Gallo KA. LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci 2006;29:286-293.
- (2006) Trends Neurosci , vol.29 , pp. 286-293
- Mata, I.F.¹ Wedemeyer, W.J.² Farrer, M.J.³ Taylor, J.P.⁴ Gallo, K.A.⁵

3
- 8844266996
- Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
- Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
- (2004) Neuron , vol.44 , pp. 595-600
- Paisan-Ruiz, C.¹ Jain, S.² Evans, E.W.³

4
- 20144387207
- Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: Evidence of a common founder across European populations
- Kachergus J, Mata IF, Hulihan M, et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 2005;76:672-680.
- (2005) Am J Hum Genet , vol.76 , pp. 672-680
- Kachergus, J.¹ Mata, I.F.² Hulihan, M.³

5
- 28344457936
- Lrrk2 pathogenic substitutions in Parkinson's disease
- Mata IF, Kachergus JM, Taylor JP, et al. Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 2005;6:171-177.
- (2005) Neurogenetics , vol.6 , pp. 171-177
- Mata, I.F.¹ Kachergus, J.M.² Taylor, J.P.³

6
- 24644486896
- A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations
- Zabetian CP, Samii A, Mosley AD, et al. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 2005;65:741-744.
- (2005) Neurology , vol.65 , pp. 741-744
- Zabetian, C.P.¹ Samii, A.² Mosley, A.D.³

7
- 33746870719
- Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease
- Tan EK, Skipper L, Chua E, et al. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease. Mov Disord 2006;21:997-1001.
- (2006) Mov Disord , vol.21 , pp. 997-1001
- Tan, E.K.¹ Skipper, L.² Chua, E.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.